First Tracks Biotherapeutics Announces $200 Million Private Placement
First Tracks Biotherapeutics agreed to sell 6,106,870 shares of common stock at $32.75 per share in a private placement. Expected gross proceeds total approximately $200 million before placement agent fees and other expenses. Closing is expected on October 19, 2026, subject to customary closing conditions. Proceeds wil